The largest database of trusted experimental protocols

Granisetron

Granisetron is a potent and selective serotonin 5-HT3 receptor antagonist used as an antiemetic to prevent and treat nausea and vomiting induced by cancer chemotherapy and radiotherapy.
It works by blocking the action of serotonin, a chemical in the brain that can trigger the vomiting reflex.
Granisetron is highly effective in controlling acute and delayed emesis, and is often used in combination with other antiemetic medications for enhanced efficacy.
Researchers can easily optimize their Granisetron studies using PubCompare.ai, an intelligent platform that facilitates effortless protocol comparisons and identification of the best approaches for reproducibility and research impact.

Most cited protocols related to «Granisetron»

The effect of different background correction methods on reproducibility was assessed using data from 20 pairs of duplicate samples that were part of a previously published study of methylation in 891 infant whole blood samples (12 (link)). As part of this study, duplicate samples were located on separate 96 well plates that underwent independent bisulfite conversion, hybridization and array scanning. One sample was excluded due to poor data quality, leaving 19 duplicate pairs (38 samples) for evaluation.
The effect of different background correction methods on measurement accuracy was assessed using data from methylation control mixture samples for this same study (12 (link)), where purified human 100% methylated and unmethylated DNA (Zymo Research, Irving CA) were mixed together in different proportions to create laboratory control samples with specific methylation levels: 0%, 5%, 10%, 20%, 40%, 50%, 60%, 80% and 100% methylated Replicates for each methylation level (n = 10, 3, 2, 3, 3, 2, 3, 3 and 10, respectively) were independently assayed on different arrays.
To avoid possible impact on evaluations, we excluded 69 075 probes, which include non-specific bind probes, common (MAF > 0.05) SNPs at CpG target regions, probes on sex chromosomes and probes with multimodal methylation distributions identified using ENmix R package. We also excluded probes with low quality methylation values where the number of beads was less than 3 or detection P-value greater than 0.05.
To demonstrate the effect of ENmix background correction method on epigenome-wide association studies (EWAS), we re-analyzed raw blood DNA methylation data from 889 infants in relation to maternal smoking (12 (link)). We preprocessed the data with different methods or combinations of methods: raw data, Q5 background correction, ENmix_oob background correction, ENmix and dye bias correction (ENmixD), ENmix+dye bias correction+quantile normalization (ENmixDQ) and ENmix+dye bias correction+quantile normalization+BMIQ (ENmixDQB). We used a robust linear regression model to test for association between maternal smoking and infant DNA methylation level adjusting for the following variables: cell type proportion (CD8T, CD4T, NK, Bcell, Mono and Gran) estimated using the Houseman method (13 (link)) from minfi R package, gestational age in weeks, sex, education in two categories, birth weight, maternal age, maternal BMI, parity, experimental batch, cleft phenotype and baby birth year.
Publication 2015
Birth Birth Weight BLOOD Cells Crossbreeding DNA Methylation Epigenome Gestational Age Granisetron Homo sapiens hydrogen sulfite Infant Methylation Mothers Multimodal Imaging Phenotype Sex Chromosomes Single Nucleotide Polymorphism
The Gervin reference was obtained from UCB samples (n = 11, 5 males and 6 females) from full-term births at the Alternative Birth Care unit at Oslo University Hospital in Norway. The Gervin reference consisted of all native Norwegians. All samples were successfully fractionated into six cell types (Gran, Mono, Bcell, CD4T, CD8T, and NK) using FACS. Notably, nRBCs were not included in this reference dataset. 450 K DNAm data was retrieved from the R package FlowSorted.CordBloodNorway.450 K in Bioconductor. For full details, refer to Gervin et al. [21 (link)].
Publication 2019
Cells Females Granisetron Males Term Birth
We analyzed the mean expression of multiple previously published gene signatures [7 (link),15 (link)-19 (link)]. Briefly, these signatures include leukocyte-related signatures from Palmer et al. [17 (link)]: CD8 (n = 10 genes), B_Cell (n = 286), T_Cell (n = 178), and GRANS (n = 353). Stromal-related signatures were obtained from West et al. [16 (link)] (n = 402; DTF and SFT signatures combined) and Beck et al. [19 (link)] (n = 174). Genes enriched more than twofold in mammosphere-derived cells compared with differentiated cells were obtained from Dontu et al. [15 (link)] (n = 58). From Shipitsin et al. [18 (link)], we calculated the mean expression of the upregulated (n = 357) and downregulated (n = 353) genes from CD44+ versus CD24+ breast cancer cells from metastatic pleural effusions. From Creighton et al. [7 (link)], we calculated the mean expression of the CD44+/CD24-/low/mammosphere signature reported (n = 119 upregulated genes; n = 279 downregulated genes). Finally, the proliferation and luminal gene cluster signatures were hand-picked (node correlation > 0.75) from the unsupervised intrinsic hierarchical clustering of the UNC337 using the intrinsic list of Parker et al. [9 (link)] and average linkage clustering using Cluster v2.12 (M. Eisen) [20 (link)] as shown in Figure S1 in Additional file 1. Gene lists from all genomic signatures are displayed in Supplemental Data in Additional file 2.
Publication 2010
B-Lymphocytes Breast Breast Carcinoma CD44 protein, human Cells Gene Clusters Genes Genome Granisetron Iron Leukocytes Neoplasm Metastasis Phenobarbital Pleural Effusion T-Lymphocyte

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2014
Anhedonia Anxiety Depression, Postpartum Disorder, Depressive Fatigue Feelings Granisetron Guilt Hypersensitivity Laceration Medically Unexplained Symptoms Panic Attacks Postpartum Women Sadness Sleep Sleep Disorders Woman
We identified four libraries (pickCompProbes raw, pickCompProbes filtered, IDOL raw, and IDOL filtered). We used heatmaps with hierarchical clustering to visualize sorted cell type methylation levels in each of the libraries selected. We used an Euler diagram to describe the relationships between the probes selected for the library methods. The selected libraries were used for deconvoluting Gran, Mono, Bcell, CD4T, CD8T, NK, and nRBCs by applying the Houseman CP/QP method to obtain cell type estimates in the test samples (n = 22). We used the combined reference dataset as well as the four reference datasets individually. The cell proportion estimates resulting from these libraries and reference datasets were compared to FACS counts for each cell type and evaluated by calculating the R2 and RMSE.
Publication 2019
cDNA Library Cells Granisetron Methylation

Most recents protocols related to «Granisetron»

We recruited patients with MyD88 or IRAK-4 deficiency who had suffered COVID-19 between the start of the pandemic and January 2022. Data were collected through an anonymized survey sent to specialists in immunology or pediatrics with reported or unreported patients with these IEIs, and through clinicians caring for patients with IEIs identified from the European Society for Immunodeficiencies (ESID) Registry. Samples were obtained from the probands, parents and relatives with written informed consent. The study was approved by the French Ethics Committee “Comité de Protection des Personnes,” the French National Agency for Medicine and Health Product Safety, the “Institut National de la Santé et de la Recherche Médicale,” in Paris, France (protocol no. C10-13), the Rockefeller University Institutional Review Board in New York, NY, USA (protocol no. JCA-0700), the Committees for Ethical Research of the University Hospital of Gran Canaria Dr. Negrínn (protocol no. 2020-200-1 COVID-19) and Hospital San Joan de Deu (protocol no. PIC-173-21), and the Office of Research & Innovation at Drexel University, Philadelphia, PA, USA (protocol no. 2112008918).
Publication 2023
COVID 19 Ethics Committees Ethics Committees, Research Europeans Granisetron Immunologic Deficiency Syndromes IRAK4 Deficiency Parent Patients Pharmaceutical Preparations Safety Specialists
Nursing Home Gran Residencia, is a public nursing home located in Madrid, Spain. Medication of residents is centrally controlled at Hospital Clínico San Carlos, in Madrid. Starting January 2021, Gran Residencia offered the BNT162b2 mRNA-based vaccine to all its residents. All of them were invited to participate in the study, finally including all those who accepted and signed the informed consent. Initially, a total of 196 NHR with or without documented pre-existing SARSCoV-2 infection were enrolled. Previous infection status was based on a positive PCR test or presence of anti-N IgG antibodies in the past or at pre-vaccination testing. The evolution of anti-RBD titer was monitoring over six months in 166 individuals out of the initially recruited. Twenty-four of these also provided paired samples for assessment of SARS-CoV-2 T-cell response. In order to investigate the influence of age and environment on IgG levels, humoral response of the residents was compared with that obtained with two different volunteer groups: nursing home staff (n = 44) and members of the association of retired health workers of the Hospital Clínico San Carlos over 65 years of age who live outside of Gran Residencia (n = 36). The two control groups were recruited similarly to residents. All of them were invited to participate in the study and all those who accepted were included. Enrolled participants completed a questionnaire, indicating age, gender, underlying conditions and usual medication (if any). A phone number was also added for future contacts. The age of all the staff was less than 65 years. The booster effect was determined only in 115 of the initially recruited individuals. The residents dropped out of the study for several reasons (own decision or that of their relatives, deterioration of their health, exitus).
Publication 2023
Anti-Antibodies Biological Evolution BNT162B2 Granisetron Health Personnel Infection mRNA Vaccine Nursing Staff Personnel, Hospital Pharmaceutical Preparations SARS-CoV-2 Secondary Immunization T-Lymphocyte Vaccination Voluntary Workers
Descriptive analyses of the study population characteristics were conducted. The study population was defined as residents who lived in Gran Residencia. Due to the characteristics of the study, the required sample size was not calculated and it was considered equal to the total number of residents who agreed to participate in the study and signed the informed consent. Data for vaccine double dose evaluation were represented as mean (standard deviation) and the median and Interquartile Range (IQR) with 95% confidence interval (95% CI). Categorical variables were represented as number and percentage. IgGs anti-RBD evolution over time and effect of the third dose were represented as log10 of BAU/mL. The log10 transformation of antibody levels was performed to simplify the construction of figures, due to the wide range of values obtained in the analysis. A Kolmogorov-Smirnov test was performed to verify normal distribution. Since there were no-normal distribution, the non-parametric Mann Whitney U test was used for comparison. Statistical significance was defined as p < 0.05. All statistical analyses were performed in IBM SPSS Statistic (version 26.0).
Publication 2023
anti-IgG Biological Evolution Granisetron Immunoglobulins Vaccines
Both groups received the MMIT regime for NACT: MTX (Haizheng Pfizer Pharmaceutical Co., Ltd., 5 mg × 5 injections) was injected intravenously at 10 g/m2 in the first and second weeks; in the third week, IFO (Guangdong Lingnan Pharmaceutical Co., Ltd., 1 g for injection) was given by intravenous drip at 2 g/m2 for 5 days, and in the third week, intravenous ADM (30 mg/m2 Shanxi Pude Pharmaceutical Co., Ltd., 10 mg × 10 injections) was administered for 3 days. With 4 weeks as a cycle, the chemotherapy was performed for two cycles. On this basis, patients in CMG were treated with rh-Endo (Shangdong Simcere Pharmaceutical Group Ltd., 15 mg: 3 mL), 15 mg per time intravenously, for 2 weeks. The granisetron, dexamethasone, and metoclopramide were routinely used for antiemetic treatment during chemotherapy, and a subcutaneous injection of colony-stimulating factor was used prophylactically after chemotherapy to protect the bone marrow. Both groups were treated for 2 cycles, and surgery was performed 2 weeks after drug withdrawal.
Publication 2023
Antiemetics Bone Marrow Colony-Stimulating Factors Dexamethasone Endometriosis Granisetron Metoclopramide Operative Surgical Procedures Patients Pharmaceutical Preparations Pharmacotherapy Subcutaneous Injections
To assess the associations between CSF biomarkers (Aβ42, pTau181, and tTau) and DNA methylation, we fitted the following linear regression model (Model 1) to CN and AD samples separately: standardized CSF biomarker ~ methylation.beta + age + methylation plate + sex + APOE4 + years of education + smoking history + immune cell-type proportions (B, NK, CD4T, Mono, Gran).
We also compared the effects of methylation-to-CSF biomarker associations in CN samples and AD samples, by fitting the following model (Model 2) to combined CN and AD samples: standardized CSF biomarker ~ methylation.beta + diagnosis + methylation.beta × diagnosis + age + methylation plate + sex + APOE4 +years of education + smoking history + immune cell-type proportions (B, NK, CD4T, Mono, Gran). Significant methylation.beta × diagnosis interaction effect corresponds to a significant difference in methylation-to-CSF biomarker associations in the CN samples and AD samples.
Publication Preprint 2023
Apolipoprotein E4 Biological Markers Cells Diagnosis DNA Methylation Granisetron Methylation

Top products related to «Granisetron»

Sourced in United States, China, United Kingdom, Germany, Australia, Japan, Canada, Italy, France, Switzerland, New Zealand, Brazil, Belgium, India, Spain, Israel, Austria, Poland, Ireland, Sweden, Macao, Netherlands, Denmark, Cameroon, Singapore, Portugal, Argentina, Holy See (Vatican City State), Morocco, Uruguay, Mexico, Thailand, Sao Tome and Principe, Hungary, Panama, Hong Kong, Norway, United Arab Emirates, Czechia, Russian Federation, Chile, Moldova, Republic of, Gabon, Palestine, State of, Saudi Arabia, Senegal
Fetal Bovine Serum (FBS) is a cell culture supplement derived from the blood of bovine fetuses. FBS provides a source of proteins, growth factors, and other components that support the growth and maintenance of various cell types in in vitro cell culture applications.
Sourced in United States, United Kingdom, Germany, China, France, Canada, Japan, Australia, Switzerland, Italy, Israel, Belgium, Austria, Spain, Brazil, Netherlands, Gabon, Denmark, Poland, Ireland, New Zealand, Sweden, Argentina, India, Macao, Uruguay, Portugal, Holy See (Vatican City State), Czechia, Singapore, Panama, Thailand, Moldova, Republic of, Finland, Morocco
Penicillin is a type of antibiotic used in laboratory settings. It is a broad-spectrum antimicrobial agent effective against a variety of bacteria. Penicillin functions by disrupting the bacterial cell wall, leading to cell death.
Sourced in United States, United Kingdom, Germany, China, France, Canada, Australia, Japan, Switzerland, Italy, Belgium, Israel, Austria, Spain, Netherlands, Poland, Brazil, Denmark, Argentina, Sweden, New Zealand, Ireland, India, Gabon, Macao, Portugal, Czechia, Singapore, Norway, Thailand, Uruguay, Moldova, Republic of, Finland, Panama
Streptomycin is a broad-spectrum antibiotic used in laboratory settings. It functions as a protein synthesis inhibitor, targeting the 30S subunit of bacterial ribosomes, which plays a crucial role in the translation of genetic information into proteins. Streptomycin is commonly used in microbiological research and applications that require selective inhibition of bacterial growth.
Sourced in United States, China, United Kingdom, Germany, France, Australia, Canada, Japan, Italy, Switzerland, Belgium, Austria, Spain, Israel, New Zealand, Ireland, Denmark, India, Poland, Sweden, Argentina, Netherlands, Brazil, Macao, Singapore, Sao Tome and Principe, Cameroon, Hong Kong, Portugal, Morocco, Hungary, Finland, Puerto Rico, Holy See (Vatican City State), Gabon, Bulgaria, Norway, Jamaica
DMEM (Dulbecco's Modified Eagle's Medium) is a cell culture medium formulated to support the growth and maintenance of a variety of cell types, including mammalian cells. It provides essential nutrients, amino acids, vitamins, and other components necessary for cell proliferation and survival in an in vitro environment.
Sourced in United States, Germany, United Kingdom, China, Canada, France, Japan, Australia, Switzerland, Israel, Italy, Belgium, Austria, Spain, Gabon, Ireland, New Zealand, Sweden, Netherlands, Denmark, Brazil, Macao, India, Singapore, Poland, Argentina, Cameroon, Uruguay, Morocco, Panama, Colombia, Holy See (Vatican City State), Hungary, Norway, Portugal, Mexico, Thailand, Palestine, State of, Finland, Moldova, Republic of, Jamaica, Czechia
Penicillin/streptomycin is a commonly used antibiotic solution for cell culture applications. It contains a combination of penicillin and streptomycin, which are broad-spectrum antibiotics that inhibit the growth of both Gram-positive and Gram-negative bacteria.
Sourced in United States, China, United Kingdom, Germany, France, Canada, Japan, Australia, Italy, Switzerland, Belgium, New Zealand, Austria, Netherlands, Israel, Sweden, Denmark, India, Ireland, Spain, Brazil, Norway, Argentina, Macao, Poland, Holy See (Vatican City State), Mexico, Hong Kong, Portugal, Cameroon
RPMI 1640 is a common cell culture medium used for the in vitro cultivation of a variety of cells, including human and animal cells. It provides a balanced salt solution and a source of essential nutrients and growth factors to support cell growth and proliferation.
Sourced in United States, China, Germany, United Kingdom, Japan, France, Canada, Australia, Italy, Switzerland, Belgium, New Zealand, Spain, Israel, Sweden, Denmark, Macao, Brazil, Ireland, India, Austria, Netherlands, Holy See (Vatican City State), Poland, Norway, Cameroon, Hong Kong, Morocco, Singapore, Thailand, Argentina, Taiwan, Province of China, Palestine, State of, Finland, Colombia, United Arab Emirates
RPMI 1640 medium is a commonly used cell culture medium developed at Roswell Park Memorial Institute. It is a balanced salt solution that provides essential nutrients, vitamins, and amino acids to support the growth and maintenance of a variety of cell types in vitro.
Sourced in United States, China, United Kingdom, Germany, Japan, Canada, France, Australia, Switzerland, Italy, Spain, India, Ireland, Israel, Austria, Brazil, Sweden, Hong Kong, Netherlands, Macao, Belgium, New Zealand, Holy See (Vatican City State), Argentina
Dulbecco's modified Eagle's medium (DMEM) is a cell culture medium formulated to support the growth and maintenance of various cell types. It provides a balanced salt solution, amino acids, vitamins, and other nutrients required for cell proliferation and survival. DMEM is a widely used medium in cell biology research and applications.
Sourced in United States, China, Germany, United Kingdom, Canada, Japan, France, Italy, Switzerland, Australia, Spain, Belgium, Denmark, Singapore, India, Netherlands, Sweden, New Zealand, Portugal, Poland, Israel, Lithuania, Hong Kong, Argentina, Ireland, Austria, Czechia, Cameroon, Taiwan, Province of China, Morocco
Lipofectamine 2000 is a cationic lipid-based transfection reagent designed for efficient and reliable delivery of nucleic acids, such as plasmid DNA and small interfering RNA (siRNA), into a wide range of eukaryotic cell types. It facilitates the formation of complexes between the nucleic acid and the lipid components, which can then be introduced into cells to enable gene expression or gene silencing studies.
Sourced in United States, Germany, United Kingdom, Italy, France, China, Macao, Poland, Switzerland, Spain, Sao Tome and Principe, Japan, Brazil, Canada, Australia, Belgium, Austria, Netherlands, Israel, India, Sweden, Denmark, Ireland, Czechia, Norway, Gabon, Argentina, Portugal, Hungary, Holy See (Vatican City State), Mexico, Ukraine, Slovakia
Streptomycin is a laboratory product manufactured by Merck Group. It is an antibiotic used in research applications.

More about "Granisetron"

Granisetron is a highly potent and selective 5-HT3 receptor antagonist, commonly used as an antiemetic medication.
It is primarily employed to prevent and treat nausea and vomiting induced by cancer chemotherapy and radiotherapy.
Granisetron works by blocking the action of serotonin, a key chemical in the brain that can trigger the vomiting reflex.
This 5-HT3 antagonist is highly effective in controlling both acute and delayed emesis, and is often used in combination with other antiemetic drugs for enhanced efficacy.
Researchers can optimize their Granisetron studies using intelligent platforms like PubCompare.ai, which facilitates effortless protocol comparisons and identification of the best approaches for reproducibility and research impact.
This AI-driven tool allows researchers to easily locate protocols from literature, pre-prints, and patents, and identify the optimal protocols and products for their Granisetron-related experiments.
When conducting Granisetron research, scientists may also utilize common cell culture materials and reagents, such as Fetal Bovine Serum (FBS), Penicillin, Streptomycin, Dulbecco's Modified Eagle's Medium (DMEM), Penicillin/Streptomycin, RPMI 1640 medium, and Lipofectamine 2000 transfection reagent.
These components play crucial roles in maintaining cell viability, preventing microbial contamination, and facilitating efficient gene delivery, which are essential for robust and reliable Granisetron-focused experiments.
By leveraging the insights from MeSH term descriptions, metadescriptions, and related cell culture materials, researchers can optimize their Granisetron studies, enhance reproducibility, and maximize the impact of their research findings.